Global Liquid Biopsy Products Market – Strategic Overview
This report provides a comprehensive assessment of the global Liquid Biopsy Products market, analyzing market size, technology adoption, competitive structure, and long-term growth potential through 2036. The market is segmented by manufacturer, technology type, sample type, clinical application, end user, and geography.
Liquid biopsy is a minimally invasive diagnostic approach that detects cancer-derived biomarkers—such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and extracellular vesicles (exosomes)—from biofluids. Compared with tissue biopsy, liquid biopsy enables earlier detection, real-time disease monitoring, therapy selection, and recurrence tracking, making it a critical tool in precision oncology.
Rapid advances in next-generation sequencing (NGS), polymerase chain reaction (PCR), and microfluidics, combined with rising global cancer prevalence, are accelerating market adoption across clinical diagnostics, pharmaceutical research, and personalized medicine.
The global Liquid Biopsy Products market was valued at US$ 620 million in 2020 and is projected to reach US$ 3,820 million by 2036, expanding at a CAGR of 25.5% during 2026–2036.
Competitive Landscape – Key Market Players
The market is technology-intensive and moderately consolidated, with innovation, regulatory approvals, and clinical validation serving as key competitive differentiators.
Established & Leading Players
-
Qiagen
-
Guardant Health
-
Biocartis
-
Sysmex Inostics
-
Menarini Silicon Biosystems
-
Angle plc
-
Adaptive Biotechnologies
-
Biocept
-
NeoGenomics Laboratories
-
RainDance Technologies
Additional & Emerging Players
-
Roche
-
Thermo Fisher Scientific
-
Agilent Technologies
-
Natera
-
Illumina
Competition is driven by assay sensitivity, biomarker breadth, turnaround time, regulatory approvals, and integration with oncology workflows.
Market Segmentation
By Technology Type
-
Circulating Tumor DNA (ctDNA)
-
Circulating Tumor Cells (CTCs)
-
Extracellular Vesicles / Exosomes
By Product Category
-
Assay kits & reagents
-
Sample preparation systems
-
Sequencing & PCR-based platforms
-
Bioinformatics & data analysis software
By Sample Type
-
Blood
-
Urine
-
Saliva
-
Cerebrospinal fluid and other biofluids
By Clinical Application
-
Early cancer screening
-
Therapy selection & companion diagnostics
-
Treatment response monitoring
-
Minimal residual disease detection
-
Recurrence monitoring
By End User
-
Hospitals & cancer centers
-
Diagnostic laboratories
-
Pharmaceutical & biotechnology companies
-
Research institutes & academic labs
By Region
-
North America
-
Europe
-
China
-
Japan
-
India
-
Southeast Asia
-
Central & South America
-
Middle East & Africa
Segments Analysis
ctDNA-based assays dominate the market due to high sensitivity, compatibility with NGS platforms, and broad applicability across solid tumors. Blood-based liquid biopsies account for the vast majority of revenue, supported by standardized workflows and clinical familiarity. Exosome-based diagnostics represent a fast-growing segment, driven by their ability to provide multi-omic insights.
Regional Analysis
-
North America: Largest market supported by advanced oncology diagnostics, high cancer prevalence, and strong reimbursement pathways
-
Europe: Strong growth driven by precision medicine initiatives and expanding molecular diagnostics infrastructure
-
China: Rapid expansion due to increasing cancer burden and domestic innovation in sequencing technologies
-
Japan: Stable growth with strong adoption in clinical oncology and companion diagnostics
-
India & Southeast Asia: High growth potential driven by rising cancer incidence and improving diagnostic access
-
Latin America & MEA: Emerging markets supported by healthcare modernization
Porter’s Five Forces Analysis
-
Threat of New Entrants: Low to moderate (high R&D and regulatory barriers)
-
Bargaining Power of Suppliers: Moderate (specialized reagents and sequencing platforms)
-
Bargaining Power of Buyers: High (hospital systems and diagnostic labs negotiate pricing)
-
Threat of Substitutes: Moderate (tissue biopsy remains standard in some settings)
-
Competitive Rivalry: High (rapid innovation cycles and IP-driven competition)
SWOT Analysis
Strengths
-
Minimally invasive and repeatable testing
-
Strong clinical relevance in oncology
-
Enables personalized treatment decisions
Weaknesses
-
High test costs in some regions
-
Complex data interpretation requirements
Opportunities
-
Expansion into early cancer screening
-
Growth of companion diagnostics
-
Integration with AI-driven bioinformatics
Threats
-
Regulatory complexity across regions
-
Reimbursement uncertainty in emerging markets
Trend Analysis
-
Increasing adoption of NGS-based liquid biopsy panels
-
Rising use in minimal residual disease detection
-
Expansion beyond oncology into prenatal and transplant monitoring
-
Integration of AI and machine learning for mutation interpretation
-
Growing pharmaceutical partnerships for drug development
Market Drivers & Challenges
Key Drivers
-
Rising global cancer incidence
-
Demand for non-invasive diagnostics
-
Growth of precision and personalized medicine
-
Technological advances in sequencing and PCR
Key Challenges
-
High cost of advanced assays
-
Variability in regulatory approval pathways
-
Limited awareness in developing regions
Value Chain Analysis
-
Biomarker discovery and assay development
-
Reagent and kit manufacturing
-
Platform integration (PCR/NGS)
-
Data analysis and interpretation
-
Clinical validation and regulatory approval
-
Distribution to diagnostic labs and hospitals
-
Clinical decision support
Key Stakeholders
-
Liquid biopsy product manufacturers
-
Diagnostic laboratories
-
Hospitals and oncology centers
-
Pharmaceutical and biotechnology companies
-
Research institutions
-
Regulatory authorities
Quick Recommendations for Stakeholders
-
Manufacturers: Focus on multi-cancer panels and MRD applications
-
Diagnostic Labs: Invest in NGS infrastructure and bioinformatics capability
-
Pharma Companies: Expand companion diagnostic collaborations
-
Healthcare Providers: Integrate liquid biopsy into routine oncology workflows
-
Investors: Target ctDNA and early screening technologies with scalable platforms
Table of Contents
Global Liquid Biopsy Products Market Research Report 2026
1 Industry Overview of Liquid Biopsy Products
1.1 Definition and Specifications of Liquid Biopsy Products
1.1.1 Definition of Liquid Biopsy Products
1.1.2 Specifications of Liquid Biopsy Products
1.2 Classification of Liquid Biopsy Products
1.2.1 CTC
1.2.2 ctDNA
1.2.3 Exosomes
1.3 Applications of Liquid Biopsy Products
1.3.1 Blood Sample
1.3.2 Urine Sample
1.3.3 Other Bio Fluids
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Liquid Biopsy Products
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Liquid Biopsy Products
2.3 Manufacturing Process Analysis of Liquid Biopsy Products
2.4 Industry Chain Structure of Liquid Biopsy Products
3 Technical Data and Manufacturing Plants Analysis of Liquid Biopsy Products
3.1 Capacity and Commercial Production Date of Global Liquid Biopsy Products Major Manufacturers
3.2 Manufacturing Plants Distribution of Global Liquid Biopsy Products Major Manufacturers
3.3 R&D Status and Technology Source of Global Liquid Biopsy Products Major Manufacturers
3.4 Raw Materials Sources Analysis of Global Liquid Biopsy Products Major Manufacturers
4 Global Liquid Biopsy Products Overall Market Overview
4.1 E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 E Global Liquid Biopsy Products Capacity and Growth Rate Analysis
4.2.2 Liquid Biopsy Products Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 E Global Liquid Biopsy Products Sales and Growth Rate Analysis
4.3.2 Liquid Biopsy Products Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 E Global Liquid Biopsy Products Sales Price
4.4.2 Liquid Biopsy Products Sales Price Analysis (Company Segment)
5 Liquid Biopsy Products Regional Market Analysis
5.1 North America Liquid Biopsy Products Market Analysis
5.1.1 North America Liquid Biopsy Products Market Overview
5.1.2 North America E Liquid Biopsy Products Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America E Liquid Biopsy Products Sales Price Analysis
5.1.4 North America Liquid Biopsy Products Market Share Analysis
5.2 Europe Liquid Biopsy Products Market Analysis
5.2.1 Europe Liquid Biopsy Products Market Overview
5.2.2 Europe E Liquid Biopsy Products Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe E Liquid Biopsy Products Sales Price Analysis
5.2.4 Europe Liquid Biopsy Products Market Share Analysis
5.3 China Liquid Biopsy Products Market Analysis
5.3.1 China Liquid Biopsy Products Market Overview
5.3.2 China E Liquid Biopsy Products Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China E Liquid Biopsy Products Sales Price Analysis
5.3.4 China Liquid Biopsy Products Market Share Analysis
5.4 Japan Liquid Biopsy Products Market Analysis
5.4.1 Japan Liquid Biopsy Products Market Overview
5.4.2 Japan E Liquid Biopsy Products Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan E Liquid Biopsy Products Sales Price Analysis
5.4.4 Japan Liquid Biopsy Products Market Share Analysis
5.5 Southeast Asia Liquid Biopsy Products Market Analysis
5.5.1 Southeast Asia Liquid Biopsy Products Market Overview
5.5.2 Southeast Asia E Liquid Biopsy Products Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia E Liquid Biopsy Products Sales Price Analysis
5.5.4 Southeast Asia Liquid Biopsy Products Market Share Analysis
5.6 India Liquid Biopsy Products Market Analysis
5.6.1 India Liquid Biopsy Products Market Overview
5.6.2 India E Liquid Biopsy Products Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India E Liquid Biopsy Products Sales Price Analysis
5.6.4 India Liquid Biopsy Products Market Share Analysis
6 Global E Liquid Biopsy Products Segment Market Analysis (by Type)
6.1 Global E Liquid Biopsy Products Sales by Type
6.2 Different Types of Liquid Biopsy Products Product Interview Price Analysis
6.3 Different Types of Liquid Biopsy Products Product Driving Factors Analysis
6.3.1 CTC Growth Driving Factor Analysis
6.3.2 ctDNA Growth Driving Factor Analysis
6.3.3 Exosomes Growth Driving Factor Analysis
7 Global E Liquid Biopsy Products Segment Market Analysis (by Application)
7.1 Global E Liquid Biopsy Products Consumption by Application
7.2 Different Application of Liquid Biopsy Products Product Interview Price Analysis
7.3 Different Application of Liquid Biopsy Products Product Driving Factors Analysis
7.3.1 Blood Sample of Liquid Biopsy Products Growth Driving Factor Analysis
7.3.2 Urine Sample of Liquid Biopsy Products Growth Driving Factor Analysis
7.3.3 Other Bio Fluids of Liquid Biopsy Products Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Liquid Biopsy Products
8.1 RainDanceTechnologies
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 RainDanceTechnologies Liquid Biopsy Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 RainDanceTechnologies Liquid Biopsy Products Business Region Distribution Analysis
8.2 Biocartis
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Biocartis Liquid Biopsy Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Biocartis Liquid Biopsy Products Business Region Distribution Analysis
8.3 Qiagen
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Qiagen Liquid Biopsy Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Qiagen Liquid Biopsy Products Business Region Distribution Analysis
8.4 Guardant Health
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Guardant Health Liquid Biopsy Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Guardant Health Liquid Biopsy Products Business Region Distribution Analysis
8.5 MDxHealth
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 MDxHealth Liquid Biopsy Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 MDxHealth Liquid Biopsy Products Business Region Distribution Analysis
8.6 Pathway Genomics
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Pathway Genomics Liquid Biopsy Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Pathway Genomics Liquid Biopsy Products Business Region Distribution Analysis
8.7 NeoGenomics Laboraories
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 NeoGenomics Laboraories Liquid Biopsy Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 NeoGenomics Laboraories Liquid Biopsy Products Business Region Distribution Analysis
8.8 Sysmex Inostics
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Sysmex Inostics Liquid Biopsy Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Sysmex Inostics Liquid Biopsy Products Business Region Distribution Analysis
8.9 Cynvenio
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Cynvenio Liquid Biopsy Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Cynvenio Liquid Biopsy Products Business Region Distribution Analysis
8.10 Menarini Silicon Biosystems
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Menarini Silicon Biosystems Liquid Biopsy Products Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Menarini Silicon Biosystems Liquid Biopsy Products Business Region Distribution Analysis
8.11 Adaptive Biotechnologies
8.12 Biocept
8.13 Angle plc
9 Development Trend of Analysis of Liquid Biopsy Products Market
9.1 Global Liquid Biopsy Products Market Trend Analysis
9.1.1 Global 2018-2025 Liquid Biopsy Products Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Liquid Biopsy Products Sales Price Forecast
9.2 Liquid Biopsy Products Regional Market Trend
9.2.1 North America 2018-2025 Liquid Biopsy Products Consumption Forecast
9.2.2 Europe 2018-2025 Liquid Biopsy Products Consumption Forecast
9.2.3 China 2018-2025 Liquid Biopsy Products Consumption Forecast
9.2.4 Japan 2018-2025 Liquid Biopsy Products Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Liquid Biopsy Products Consumption Forecast
9.2.6 India 2018-2025 Liquid Biopsy Products Consumption Forecast
9.3 Liquid Biopsy Products Market Trend (Product Type)
9.4 Liquid Biopsy Products Market Trend (Application)
10 Liquid Biopsy Products Marketing Type Analysis
10.1 Liquid Biopsy Products Regional Marketing Type Analysis
10.2 Liquid Biopsy Products International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Liquid Biopsy Products by Region
10.4 Liquid Biopsy Products Supply Chain Analysis
11 Consumers Analysis of Liquid Biopsy Products
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Liquid Biopsy Products Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Liquid Biopsy Products
Table Product Specifications of Liquid Biopsy Products
Table Classification of Liquid Biopsy Products
Figure Global Production Market Share of Liquid Biopsy Products by Type in
Figure CTC Picture
Table Major Manufacturers of CTC
Figure ctDNA Picture
Table Major Manufacturers of ctDNA
Figure Exosomes Picture
Table Major Manufacturers of Exosomes
Table Applications of Liquid Biopsy Products
Figure Global Consumption Volume Market Share of Liquid Biopsy Products by Application in
Figure Blood Sample Examples
Table Major Consumers in Blood Sample
Figure Urine Sample Examples
Table Major Consumers in Urine Sample
Figure Other Bio Fluids Examples
Table Major Consumers in Other Bio Fluids
Figure Market Share of Liquid Biopsy Products by Regions
Figure North America Liquid Biopsy Products Market Size (Million USD) (2013-2025)
Figure Europe Liquid Biopsy Products Market Size (Million USD) (2013-2025)
Figure China Liquid Biopsy Products Market Size (Million USD) (2013-2025)
Figure Japan Liquid Biopsy Products Market Size (Million USD) (2013-2025)
Figure Southeast Asia Liquid Biopsy Products Market Size (Million USD) (2013-2025)
Figure India Liquid Biopsy Products Market Size (Million USD) (2013-2025)
Table Liquid Biopsy Products Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Liquid Biopsy Products in
Figure Manufacturing Process Analysis of Liquid Biopsy Products
Figure Industry Chain Structure of Liquid Biopsy Products
Table Capacity and Commercial Production Date of Global Liquid Biopsy Products Major Manufacturers
Table Manufacturing Plants Distribution of Global Liquid Biopsy Products Major Manufacturers
Table R&D Status and Technology Source of Global Liquid Biopsy Products Major Manufacturers
Table Raw Materials Sources Analysis of Global Liquid Biopsy Products Major Manufacturers
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Liquid Biopsy Products E
Figure Global E Liquid Biopsy Products Market Size (Volume) and Growth Rate
Figure Global E Liquid Biopsy Products Market Size (Value) and Growth Rate
Table E Global Liquid Biopsy Products Capacity and Growth Rate
Table Global Liquid Biopsy Products Capacity (K Units) List (Company Segment)
Table E Global Liquid Biopsy Products Sales (K Units) and Growth Rate
Table Global Liquid Biopsy Products Sales (K Units) List (Company Segment)
Table E Global Liquid Biopsy Products Sales Price (USD/Unit)
Table Global Liquid Biopsy Products Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Liquid Biopsy Products E
Figure North America E Liquid Biopsy Products Sales Price (USD/Unit)
Figure North America Liquid Biopsy Products Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Liquid Biopsy Products E
Figure Europe E Liquid Biopsy Products Sales Price (USD/Unit)
Figure Europe Liquid Biopsy Products Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Liquid Biopsy Products E
Figure China E Liquid Biopsy Products Sales Price (USD/Unit)
Figure China Liquid Biopsy Products Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Liquid Biopsy Products E
Figure Japan E Liquid Biopsy Products Sales Price (USD/Unit)
Figure Japan Liquid Biopsy Products Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Liquid Biopsy Products E
Figure Southeast Asia E Liquid Biopsy Products Sales Price (USD/Unit)
Figure Southeast Asia Liquid Biopsy Products Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Liquid Biopsy Products E
Figure India E Liquid Biopsy Products Sales Price (USD/Unit)
Figure India Liquid Biopsy Products Sales Market Share
Table Global E Liquid Biopsy Products Sales (K Units) by Type
Table Different Types Liquid Biopsy Products Product Interview Price
Table Global E Liquid Biopsy Products Sales (K Units) by Application
Table Different Application Liquid Biopsy Products Product Interview Price
Table RainDanceTechnologies Information List
Table Product Overview
Table RainDanceTechnologies Liquid Biopsy Products Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure RainDanceTechnologies Liquid Biopsy Products Business Region Distribution
Table Biocartis Information List
Table Product Overview
Table Biocartis Liquid Biopsy Products Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Biocartis Liquid Biopsy Products Business Region Distribution
Table Qiagen Information List
Table Product Overview
Table Qiagen Liquid Biopsy Products Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Qiagen Liquid Biopsy Products Business Region Distribution
Table Guardant Health Information List
Table Product Overview
Table Guardant Health Liquid Biopsy Products Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Guardant Health Liquid Biopsy Products Business Region Distribution
Table MDxHealth Information List
Table Product Overview
Table MDxHealth Liquid Biopsy Products Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure MDxHealth Liquid Biopsy Products Business Region Distribution
Table Pathway Genomics Information List
Table Product Overview
Table Pathway Genomics Liquid Biopsy Products Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Pathway Genomics Liquid Biopsy Products Business Region Distribution
Table NeoGenomics Laboraories Information List
Table Product Overview
Table NeoGenomics Laboraories Liquid Biopsy Products Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure NeoGenomics Laboraories Liquid Biopsy Products Business Region Distribution
Table Sysmex Inostics Information List
Table Product Overview
Table Sysmex Inostics Liquid Biopsy Products Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Sysmex Inostics Liquid Biopsy Products Business Region Distribution
Table Cynvenio Information List
Table Product Overview
Table Cynvenio Liquid Biopsy Products Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Cynvenio Liquid Biopsy Products Business Region Distribution
Table Menarini Silicon Biosystems Information List
Table Product Overview
Table Menarini Silicon Biosystems Liquid Biopsy Products Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Menarini Silicon Biosystems Liquid Biopsy Products Business Region Distribution
Table Adaptive Biotechnologies Information List
Table Biocept Information List
Table Angle plc Information List
Figure Global 2018-2025 Liquid Biopsy Products Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Liquid Biopsy Products Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Liquid Biopsy Products Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Liquid Biopsy Products Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Liquid Biopsy Products Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Liquid Biopsy Products Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Liquid Biopsy Products Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Liquid Biopsy Products Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Liquid Biopsy Products Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Liquid Biopsy Products by Type 2018-2025
Table Global Consumption Volume (K Units) of Liquid Biopsy Products by Application 2018-2025
Table Traders or Distributors with Contact Information of Liquid Biopsy Products by Region
Competitive Landscape – Key Market Players
The market is technology-intensive and moderately consolidated, with innovation, regulatory approvals, and clinical validation serving as key competitive differentiators.
Established & Leading Players
-
Qiagen
-
Guardant Health
-
Biocartis
-
Sysmex Inostics
-
Menarini Silicon Biosystems
-
Angle plc
-
Adaptive Biotechnologies
-
Biocept
-
NeoGenomics Laboratories
-
RainDance Technologies
Additional & Emerging Players
-
Roche
-
Thermo Fisher Scientific
-
Agilent Technologies
-
Natera
-
Illumina
Competition is driven by assay sensitivity, biomarker breadth, turnaround time, regulatory approvals, and integration with oncology workflows.
Market Segmentation
By Technology Type
-
Circulating Tumor DNA (ctDNA)
-
Circulating Tumor Cells (CTCs)
-
Extracellular Vesicles / Exosomes
By Product Category
-
Assay kits & reagents
-
Sample preparation systems
-
Sequencing & PCR-based platforms
-
Bioinformatics & data analysis software
By Sample Type
-
Blood
-
Urine
-
Saliva
-
Cerebrospinal fluid and other biofluids
By Clinical Application
-
Early cancer screening
-
Therapy selection & companion diagnostics
-
Treatment response monitoring
-
Minimal residual disease detection
-
Recurrence monitoring
By End User
-
Hospitals & cancer centers
-
Diagnostic laboratories
-
Pharmaceutical & biotechnology companies
-
Research institutes & academic labs
By Region
-
North America
-
Europe
-
China
-
Japan
-
India
-
Southeast Asia
-
Central & South America
-
Middle East & Africa
